AssetMark Inc’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.8K Hold
1,495
﹤0.01% 1896
2026
Q1
$42.7K Sell
1,495
-76
-5% -$2.59K ﹤0.01% 1805
2025
Q4
$62.1K Hold
1,571
﹤0.01% 1642
2025
Q3
$55.4K Hold
1,571
﹤0.01% 1598
2025
Q2
$51.5K Buy
1,571
+185
+13% +$6.01K ﹤0.01% 1556
2025
Q1
$44.7K Hold
1,386
﹤0.01% 1465
2024
Q4
$42.4K Sell
1,386
-20
-1% -$643 ﹤0.01% 1466
2024
Q3
$39.4K Sell
1,406
-27,910
-95% -$688K ﹤0.01% 1344
2024
Q2
$668K Buy
29,316
+7,963
+37% +$184K ﹤0.01% 833
2024
Q1
$650K Buy
21,353
+3,856
+22% +$129K ﹤0.01% 793
2023
Q4
$624K Buy
17,497
+7,451
+74% +$277K ﹤0.01% 764
2023
Q3
$440K Buy
10,046
+1,537
+18% +$75K ﹤0.01% 779
2023
Q2
$420K Buy
8,509
+1,665
+24% +$76.7K ﹤0.01% 756
2023
Q1
$284K Buy
6,844
+865
+14% +$35.9K ﹤0.01% 785
2022
Q4
$265K Buy
5,979
+1,689
+39% +$70.5K ﹤0.01% 786
2022
Q3
$168K Buy
4,290
+1,398
+48% +$64K ﹤0.01% 786
2022
Q2
$118K Buy
2,892
+1,428
+98% +$67.6K ﹤0.01% 800
2022
Q1
$96K Buy
1,464
+454
+45% +$29.4K ﹤0.01% 797
2021
Q4
$70K Hold
1,010
﹤0.01% 845
2021
Q3
$70K Hold
1,010
﹤0.01% 715
2021
Q2
$80K Sell
1,010
-25
-2% -$1.82K ﹤0.01% 668
2021
Q1
$68K Hold
1,035
﹤0.01% 684
2020
Q4
$58K Hold
1,035
﹤0.01% 687
2020
Q3
$41K Hold
1,035
﹤0.01% 709
2020
Q2
$47K Sell
1,035
-150
-13% -$6.53K ﹤0.01% 659
2020
Q1
$40K Sell
1,185
-90
-7% -$3.24K ﹤0.01% 729
2019
Q4
$41K Buy
1,275
+300
+31% +$8.54K ﹤0.01% 784
2019
Q3
$24K Hold
975
﹤0.01% 852
2019
Q2
$29K Buy
975
+510
+110% +$14.9K ﹤0.01% 815
2019
Q1
$12K Hold
465
﹤0.01% 959
2018
Q4
$14K Buy
+465
New +$14.5K ﹤0.01% 943

Other funds holding ATRC

AssetMark Inc's ATRC Position: Q2 2026 in Review

AssetMark Inc held its AtriCure (ATRC) position steady in Q2 2026 at 1,495 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1896.

AssetMark Inc first reported a position in ATRC in Q4 2018 and has held it in 31 quarters since. The position peaked at $668K in Q2 2024. 41 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • AssetMark Inc held 1,495 shares of AtriCure worth $41.8K as of Q2 2026.
  • AssetMark Inc left its AtriCure share count unchanged in Q2 2026.
  • AtriCure made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1896 holding.
  • AssetMark Inc first reported a position in AtriCure in Q4 2018 and has held it in 31 quarters since.
  • AssetMark Inc's AtriCure position peaked at $668K in Q2 2024.
  • 41 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.